NCT06895954View on ClinicalTrials.gov

The Clinical Study on Isoflavone Genistein in Restructuring the Gut Microbiota of Hyperlipidemia Patients

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 13, 2024

Primary Completion Date

February 20, 2025

Study Completion Date

February 20, 2025

Conditions
Hyperlipidemia
Interventions
DIETARY_SUPPLEMENT

Genistein

Hyperlipidemia patients take a 125mg Genistein capsule daily, once a day.

Trial Locations (1)

0086510282

Shenzhen Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Shenzhen Hospital of Southern Medical University

OTHER

NCT06895954 - The Clinical Study on Isoflavone Genistein in Restructuring the Gut Microbiota of Hyperlipidemia Patients | Biotech Hunter | Biotech Hunter